Efficacy & Safety of Hizikia Fusiformis Extract in Subjects Showing

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The investigators performed a double-blind parallel study in a group of Subjects Showing Erosive Gastritis who were given Hizikia Fusiformis Extract over a period of 4 weeks. Endoscopic observations were performed before and 4 weeks after the treatment, and the cure and improvement rates were investigated.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00854880` - A Clinical Trial to Evaluate the Efficacy and Safety of PDC-339 for the Treatment of Acute Erosive Gastritis	Phase 2
	Completed	`NCT01578811` - Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis	Phase 2

NCT number	NCT01689701
Study type	Interventional
Source	Chonbuk National University Hospital
Contact
Status	Completed
Phase	N/A
Start date	August 2011
Completion date	April 2012

Efficacy and Safety of Hizikia Fusiformis Extract in Subjects Showing Erosive Gastritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms